3 completed, 1 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 3, Terminated 1 |
Follow Genital Warts: new trials by email Literature Review of Genital Warts trials Research Report on Genital Warts
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts Oral Zinc, Placebo - Genital Warts, HPV | Phase 4 | Terminated | University of British Columbia | 50 | 2011-11-01 | 2016-11-02 |
| Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage Polyphenon E (Veregen) 15% ointment, Green Tea Beverage with defined catechin content - Genital Warts, Perianal Warts | Phase 4 | Completed | MediGene | 43 | 2010-01-01 | 2010-09-08 |
| Alternate Dosing Schedules Study for HPV Vaccine Received HPV vaccine first, Received concomitant vaccines first - Cervical Cancer, Genital Warts | Phase 4 | Completed | Duke University | 72 | 2009-03-01 | 2014-11-20 |
| Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts Imiquimod, vehicle cream - Genital Warts | Phase 4 | Completed | MEDA Pharma GmbH & Co. KG | 128 | 2005-06-01 | 2022-02-07 |
Condylomata Acuminata (4) · Uterine Cervical Neoplasms (1) · Warts (1)
Communicable Diseases (4) · DNA Virus Infections (4) · Disease Attributes (4) · Genital Diseases (4) · Infections (4) · Papillomavirus Infections (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Sexually Transmitted Diseases (4) · Sexually Transmitted Diseases, Viral (4) · Skin Diseases (4) · Skin Diseases, Infectious (4) · Skin Diseases, Viral (4) · Skin and Connective Tissue Diseases (4) · Tumor Virus Infections (4)
Imiquimod (1) · Ointments (1) · Zinc (1) · green tea extract polyphenone E (1) · polyphenon E (1)
Duke University (1) · MEDA Pharma GmbH & Co. KG (1) · MediGene (1) · University of British Columbia (1)
Canada (1) · Germany (1) · Italy (1) · United States (1)
Emmanuel B Walter, MD (1) · Fausto Boselli, MD (1) · Frank Wagner, Md, PD (1) · Richard Lester (1)
2004 (1)